Introduction {#S1}
============

Ross syndrome (RS) is a rare disorder characterized by segmental anhidrosis, tonic pupil, and hyporeflexia first reported by [@B10]. [@B12] then found a selective loss of cholinergic sudomotor fibers in Ross patients. Interestingly, [@B8] discovered that impairment of heat production and dissipation in Ross patients are associated with cutaneous sensory and autonomic innervation.

Given that the autonomic nervous system features in many neurological disorders, it plays an essential role in regulating physiological homeostasis, for example, in α-synucleinopathies. α-Synucleinopathies are a group of neurodegenerative diseases characterized by the abnormal accumulation of α-synuclein (α-Syn) aggregates in neurons, glial cells, or nerve fibers, including Parkinson's disease (PD), Lewy body dementia (LBD), and multiple system atrophy (MSA). Pure autonomic failure (PAF) is also suggested to be an α-synucleinopathy, and pathologic findings show that lesions in the peripheral autonomic nervous system of PAF are associated with α-Syn-positive deposits ([@B13]).

In this study, we investigated neuropathological changes or innervation of skin, stomach, and bladder from patients with RS, PAF, PD, or MSA. We found that α-Syn aggregates deposit in autonomic nerve terminals of skin and lesser curvature of stomach in patients with RS. Our findings provide evidence that RS belongs to α-synucleinopathies, which has not been recognized before. Additionally, immunohistochemical studies showed that there is a dominant loss of cholinergic fibers in patients with RS, while the mainly damaged fibers are adrenergic in patients with PAF.

Materials and Methods {#S2}
=====================

Subjects {#S2.SS1}
--------

Twenty-three patients (11 men, 12 women; 47--66 years of age) with RS (2 patients), PAF (6 patients), PD (10 patients), or MSA (5 patients) referred to our Neurology Clinic were recruited according to clinical features and consensus diagnostic criteria ([@B10]; [@B3]; [@B4]; [@B13]). The normal controls were randomly selected from the gastroscopy clinic patients with superficial gastritis (six subjects) or the cystoscopy clinic patients with chronic cystitis (six subjects); all of them were free of neurological symptoms. Demographic data and autonomic symptoms of the tested patients are summarized in [Table 1](#T1){ref-type="table"}.

###### 

Clinical and demographic data.

  **Diagnosis**   **Age, y**   **Sex**   **Disease duration, y**   **Autonomic dysfunction**                  
  --------------- ------------ --------- ------------------------- --------------------------- ---- ---- ---- ----
  RS              50           F         10                        \+                          −    \+   −    \+
  RS              47           M         4                         \+                          −    −    −    \+
  PAF             49           M         5                         \+                          \+   −    \+   \+
  PAF             54           M         1                         −                           \+   \+   −    −
  PAF             61           F         1                         −                           \+   \+   −    −
  PAF             58           M         4                         −                           \+   −    −    −
  PAF             63           F         6                         −                           \+   \+   −    −
  PAF             51           M         3                         −                           \+   −    \+   −
  PD              54           F         10                        −                           −    −    −    −
  PD              58           F         3                         −                           −    −    −    −
  PD              61           M         6                         −                           −    \+   \+   −
  PD              65           F         4                         −                           −    \+   \+   −
  PD              54           F         10                        −                           −    −    \+   −
  PD              56           F         1                         −                           −    −    \+   −
  PD              54           F         3                         −                           −    \+   −    −
  PD              63           M         1                         −                           \+   \+   −    −
  PD              54           M         1                         −                           −    \+   \+   −
  PD              64           F         8                         −                           −    \+   −    −
  MSA             66           F         3                         −                           −    \+   \+   −
  MSA             54           M         2                         −                           −    \+   \+   −
  MSA             59           M         2                         −                           −    \+   \+   −
  MSA             50           M         2                         −                           −    −    \+   −
  MSA             57           F         8                         −                           −    \+   \+   −

+, abnormal finding; −, normal finding. F, female; GP, gastrointestinal paresis; IS, impotence and sexual dysfunction; M, male; MSA, multiple system atrophy; OH, orthostatic hypotension; PAF, pure autonomic failure; PD, Parkinson's disease; RS, Ross syndrome; SL, sweat loss; UI, urinary incontinence; y, years.

Sweating Function {#S2.SS2}
-----------------

### Thermoregulatory Sweat Test (TST) {#S2.SS2.SSS1}

TST was performed as previously described ([@B8]). The subject's face was covered with a 2% alcoholic solution of iodine and with rice starch powder except for eyes in a prescriptive room. The color of the rice starch powder changes to black while sweating. Digital pictures were taken using a Canon camera (EOS 200D II, Canon).

### Digital Infrared Thermal Imaging (DITI) {#S2.SS2.SSS2}

DITI was performed according to a previous publication ([@B6]). The subjects removed clothing and sat quietly in a prescriptive room. Colored pictures were taken using the DITI system. Black, purple, blue, green, yellow, brown, red, and grayish white in the pictures represented temperatures from low to high.

Skin, Gastric, and Bladder Biopsies {#S2.SS3}
-----------------------------------

Biopsies were conducted by experienced endoscopists or urologists in a procedure room. Skin samples were obtained from the left (hyperhidrotic site) and right (anhidrotic site) inner aspect of the upper arms in patients with RS. Gastric biopsy samples from patients were acquired from the lesser curvature and antrum regions during percutaneous endoscopic gastroscopy, and the samples from normal controls were randomly selected from gastric biopsies in gastritis patients who attended the gastroscopy clinic. Bladder tissues from patients were obtained during cystoscopy, and the tissues from normal controls were randomly selected from bladder biopsies in cystitis patients who attended the cystoscopy clinic. All biopsies were immediately fixed in 30% sucrose solution containing 4% paraformaldehyde and embedded in paraffin blocks. Immunohistochemical and immunofluorescence analyses were performed as described before ([@B2]). For immunohistochemical analysis, endogenous tissue peroxidases were inhibited by incubating the slides in 3% hydrogen peroxide solution. Slides were then blocked with normal goat serum for 20 min and then incubated with primary antibodies: Ser129phospho-α-Syn (pα-Syn) (1:600, mouse, Millipore, MABN826), α-Syn filament (1:500, rabbit, Abcam, ab209538), and protein gene product 9.5 (PGP 9.5) (1:300, rabbit, Abcam, ab108986). Bound antibodies were detected using a Streptavidin-Peroxidase kit (Bioss and Proteintech, China) and visualized using 3-3′-diaminobenzidine (DAB; Neobioscience). Slides were counterstained with hematoxylin. For immunofluorescence analysis, slides were blocked with 5% BSA for 30 min at room temperature and then incubated with combinations of primary antibodies: Ser129phospho-α-Syn (pα-Syn) (1:800, mouse, Millipore, MABN826), PGP 9.5 (1:300, rabbit, Abcam, ab108986), vasoactive intestinal peptide (VIP) (1:300, mouse, Abcam, ab30680), Tyrosine Hydroxylase (TH) (1:600, mouse, Santa Cruz Biotechnology, sc-25269), and anti-Vesicular Acetylcholine Transporter (VAChT) (1:300, goat, Millipore, ABN100). Cell nuclei were stained using Hoechst 33258 (1:1000, Solarbio, C0021). Digital images were captured using an Olympus IX51 microscope mounted with a DP71 Olympus digital camera. Photoshop CS6 (Adobe Systems) was used to assemble montages. Data from immunohistochemistry and immunofluorescence were quantified using ImageJ Software.

Statistical Analysis {#S2.SS4}
--------------------

Statistical analysis of behavioral data was performed using SPSS 21.0 (IBM, Armonk, NY, United States). Student's *t*-test was employed for comparison between two groups, while one-way ANOVA was used for three groups when the data were distributed normally (*P \<* 0.05 by Shapiro--Wilk test). Otherwise, the analysis of variance corrected for multiple comparisons was utilized. *P* \< 0.05 was considered statistically significant.

Results {#S3}
=======

Clinical Characteristics and Autonomic Symptoms {#S3.SS1}
-----------------------------------------------

Twenty-three subjects with RS, PAF, PD, or MSA participated in the study. Among these subjects, two patients with RS presented with unilateral anhidrosis and bilateral tonic pupils ([Figure 1C](#F1){ref-type="fig"}), their blood tests and physical examination were normal, but neurological examination revealed diffuse bilateral hyporeflexia in all the four limbs. Furthermore, TST confirmed segmental anhidrosis involved in the body surface of Ross patients ([Figure 1A](#F1){ref-type="fig"}), and DITI revealed that the mean skin temperature of the anhidrosis area was higher than that of the hyperhidrosis area ([Figure 1B](#F1){ref-type="fig"}). Additionally, various symptoms of autonomic dysfunction identified in patients participated are shown in [Table 1](#T1){ref-type="table"}. Both patients with RS displayed segmental sweat loss and gastrointestinal paresis. All PAF patients had orthostatic hypotension.

![Morphologic and functional features of patients and normal controls. **(A)** Thermoregulatory sweat test (iodine-starch method). Hypohidrosis is seen mainly on the right side of the face. **(B)** Digital infrared thermal imaging shows a lower temperature in the left side of the face than the right. **(C)** Pupillary light reflex appears sluggish in the right eye, but normal in the left eye. **(D--G)** VIP immunoreactive fibers appeared more frequently in the skin of normal controls **(D,E)** than in Ross patients **(F,G)**. In Ross patients, rare VIP immunoreactive fibers were found around sweat glands in anhidrotic skin **(F)**, while VIP-ir fibers appeared more frequently in hyperhidrotic skin **(G)**. **(H--K)**. The PGP 9.5-ir fibers appeared more frequently in the skin of normal controls **(H,I)** than in Ross patients **(J,K)**. In Ross patients, the PGP 9.5-ir fibers were severely reduced in anhidrotic skin **(J)** and slightly reduced in hyperhidrotic skin **(K)**.](fnins-14-00635-g001){#F1}

Pathological α-Syn Deposits in Skin and Gastric Nerve Terminals of Patients With RS {#S3.SS2}
-----------------------------------------------------------------------------------

Immunohistochemical analysis revealed that VIP-immunoreactive (VIP-ir) fibers around sweat glands were severely decreased in the skin of Ross patients than in the skin of normal controls ([Figures 1D--G](#F1){ref-type="fig"}). Moreover, rare VIP-ir fibers were found in anhidrotic skin of Ross patients ([Figure 1F](#F1){ref-type="fig"}), while they were moderately decreased in hyperhidrotic skin ([Figure 1G](#F1){ref-type="fig"}). In addition, we observed a slightly increased loss of PGP 9.5-ir fibers in the skin of Ross patients than in normal controls ([Figures 1H--K](#F1){ref-type="fig"}). Moreover, PGP 9.5-ir fibers were severely reduced in Ross patients' anhidrotic skin ([Figure 1J](#F1){ref-type="fig"}) than in hyperhidrotic skin ([Figure 1K](#F1){ref-type="fig"}). Furthermore, phospho-α-Syn-ir (pα-Syn-ir) inclusions and α-Syn filament were found in nerve terminals in dermis and subcutaneous tissues of Ross patients ([Figures 2A--D](#F2){ref-type="fig"}). To determine whether pathological α-Syn accumulates in nerve terminals of gastrointestinal tract and bladder, we performed immunohistochemistry on gastric and bladder samples using anti-pα-Syn (Ser129pα-Syn, mouse, Millipore) and anti-α-Syn filament (rabbit, Abcam) antibodies. We found that pathological α-Syn deposited in the lesser curvature of stomach in both of the Ross patients (100%), 6 out of 10 PD cases biopsied (60.0%), 2 of 6 PAF cases (33.3%), but none from MSA patients or normal controls ([Figures 2I--P](#F2){ref-type="fig"}). Moreover, double-immunofluorescent staining showed that pα-Syn was deposited within nerve terminals in the skin ([Figures 2E--H](#F2){ref-type="fig"}) and surrounding gastric glands of RS patients ([Figures 2Q--T](#F2){ref-type="fig"}). No α-Syn-positive inclusions were detected in bladder tissues of RS patients (data not shown).

![Pathological α-Syn immunoreactivity in patients with Ross syndrome, PAF PD, MSA, and normal controls. **(A--D,I--P)** Some of fibers were positive for pα-Syn inclusions **(A,B,I,J)** or α-Syn filament **(C,D,K,L)** in anhidrotic skin **(A--D)** and lesser curvature of stomach **(I--L)**. **(M--P)** α-Syn filament was present in lesser curvature of stomach in PAF **(M)** and PD **(N)**, but not in MSA **(O)** and normal controls **(P)**. **(E--H,Q--T)** Double immunofluorescence analysis showed that pα-Syn colocalized with panaxonal marker PGP 9.5 in the skin **(E--H)** and lesser curvature of stomach **(Q--T)** from the patients with RS. Bar = 100 μm.](fnins-14-00635-g002){#F2}

Selective Loss of Cholinergic Innervation in RS Patients and Adrenergic Innervation in PAF Patients in Gastrointestinal and Urinary System {#S3.SS3}
------------------------------------------------------------------------------------------------------------------------------------------

PGP 9.5-ir nerve fibers in stomach were significantly decreased in patients with RS and PAF, compared with normal controls ([Figures 1H--K](#F1){ref-type="fig"}). Double immunofluorescence analysis showed that VIP-ir nerve fibers were profoundly decreased in lesser curvature of stomach from RS patients ([Figures 3A--C,O](#F3){ref-type="fig"}), while TH-ir nerve fibers were decreased in lesser curvature of stomach from PAF ([Figures 3D--F,O](#F3){ref-type="fig"}). These findings indicate that there is a preferential loss of cholinergic innervation in RS patients, while predominant loss of adrenergic innervation in PAF patients in the gastrointestinal tract. Furthermore, VIP-ir pα-Syn appeared more frequently than TH-ir pα-Syn in the lesser curvature of stomach ([Figures 3G,H](#F3){ref-type="fig"}). In addition, immunofluorescence analytical result of bladder biopsy showed selective loss of cholinergic innervation in RS patients ([Figures 3I--K](#F3){ref-type="fig"}) and adrenergic innervation in PAF patients in bladder ([Figures 3K--N,P](#F3){ref-type="fig"}).

![Histopathological features in patients with Ross syndrome, PAF, and normal controls. **(A--F)** Double immunofluorescence analysis of lesser curvature of stomach: Nerve fibers are marked in green using PGP 9.5; cholinergic fibers and adrenergic fibers are stained in red by anti-VIP and anti-TH antibodies. VIP-ir fibers appear poorly represented in RS **(A)**, while they were evident in PAF **(B)** and normal controls **(C)**. TH-ir fibers were present in Ross patients **(D)** and normal controls **(F)**, while they were reduced in PAF **(E)**. **(G,H)** Double immunofluorescence analysis of lesser curvature of stomach; VIP-ir pα-Syn **(G)** appeared more frequently than TH-ir pα-Syn **(H)**. **(I--N)** Double immunofluorescence study of urinary bladder innervation. VIP-ir fibers appear poorly represented in RS **(I)**, while they were evident in PAF **(J)** and normal controls **(K)**. TH-ir fibers were present in Ross patients **(L)** and normal controls **(N)**, while they were reduced in PAF **(M)**. **(O,P)** Quantification of VIP-ir fibers and TH-ir fibers in the lesser curvature of stomach **(O)** and bladder **(P)**, respectively. Bar = 100 μm. \**P* \< 0.05.](fnins-14-00635-g003){#F3}

Discussion {#S4}
==========

[@B1] reported that RS is a rare peripheral autonomic dysfunction characterized by selective loss of cholinergic fibers. To date, the underlying disease mechanism remains unclear ([@B15]; [@B9]; [@B11]; [@B7]; [@B14]). α-Synucleinopathies share the pathological hallmark of α-Syn insoluble inclusions in neurons, glial cells, or nerve fibers ([@B5]) and often present with prominent autonomic symptoms. Our findings show that pathological α-Syn deposited in the autonomic nerve terminals of samples from patients with RS. It provides preliminary evidence that RS may belong to α-synucleinopathies. We surmise that selective loss of cholinergic fibers may be associated with accumulations of pathological α-Syn in the nerve terminals. These findings may shed new light on the correlation between disorders of peripheral autonomic nervous system and α-synucleinopathy, which warrants further investigation.

Furthermore, immunofluorescence analysis revealed that gastric and urinary bladder innervation was decreased in patients with RS and PAF. Moreover, we found selective loss of cholinergic innervation in patients with RS while adrenergic innervation in patients with PAF. It is suggested that different phenotypes of autonomic failure may be attributed to pathological changes of different types of autonomic nerve fibers. However, this current study is limited by its small sample size and our preliminary findings will certainly need to be confirmed by future work.

Conclusion {#S5}
==========

Our study suggests that RS belongs to α-synucleinopathies. Moreover, our findings indicate that adrenergic nerves and cholinergic nerves are not equally damaged in different types of pure autonomic dysfunctions.
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